Treatment as Prevention named in Time Magazine’s “Top 10 Medical Breakthroughs of 2011”

The treatment of HIV has come a long way, thanks to antiretroviral (ARV) drugs that can lower levels of the virus in the body, keeping people healthy and reducing the risk of HIV transmission. Increasingly, though, studies have also shown that the same drugs used to treat existing infections can also help protect HIV-free people from becoming infected.

This year, two groundbreaking trials – the first to involve heterosexual men and women – showed that HIV-free people were significantly less likely to become infected with the virus if they took the antiretroviral drug Truvada (a combination pill that contains the drugs tenofovir and emtricitabine) every day.

More >>

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below